Metabolic Stack

Two compounds, two different levers on metabolic research. Retatrutide is the receptor-agonist approach — a triple-agonist engaging GLP-1, GIP, and glucagon receptors directly. MOTS-c comes at it from the mitochondrial side, a peptide encoded in mitochondrial DNA and studied for AMPK activation and cellular energy signaling. Studied together, the pairing covers receptor-level and mitochondrial-level mechanisms across the same broad research question: how cells regulate energy expenditure and fat metabolism.